3D Printed Devices and Biocompatibility: Post-Printing and Finishing
We are happy to announce Nelson Labs will be exhibiting in booth #450 with our sister company Sterigenics at the 2021 BIOMEDevice Boston tradeshow, in Boston, Massachusetts on April 21-22, 2021
Nelson Labs will have consultants available to BIOMEDevice Boston participants to answer even the most difficult testing and compliance questions. Stop by booth #450 for a complimentary personalized 30 minute consultation, and mark your calendar for Nelson Labs’ educational lectures, and roundtable debate (additional details provided below).
Nelson Laboratories’ BIOMEDevice BostonEvents:
Tech Theater Lecture (Free)
Topic: 3D Printed Devices and Biocompatibility: Post-Printing and Finishing
Date: Thursday April, 21
Time: 11:30am – 12:15pm
Location: Center Stage
Presenter: Matthew R Jorgensen, PhD, DABT (Nelson Labs); Aaron Anderson (Stratasys)
Personalized devices produced using additive manufacturing present a special challenge from the perspective of biocompatibility, especially when the material is a polymer and chemistry for toxicology “ChemTox” is involved. This presentation will provide an overview of the state-of-the-art of 3D printed medical devices from the perspective of a manufacturer and guidance on the strategy to conduct biocompatibility evaluations of 3D printed devices from the perspective of a lab. There will be hands-on examples, with discussion focusing on specifics related to sample preparation, test method selection, appropriate analytical techniques, and toxicological risk assessment. As the standards and expectations of medical device chemistry testing have been rapidly evolving, an overview of these changes will be discussed with attention to new requirements and potential gaps in current approaches. Special attention will be given to a case study of a 3D printed medical device that was recently tested for biocompatibility.
Dr. Jorgensen is the Senior Extractables and Leachables Chemistry Expert at Nelson Labs. He has over a decade of experience in chemistry and materials science designing, synthesizing, and analyzing complex materials. His analytical chemistry background includes academic research in organic chemistry, computational treatments of various analytical techniques, and as professional in a commercial lab. Most of his materials research has focused on the intersection between chemistry, materials, and physics – fabricating structures with special micro- and nano-patterning to introduce novel functionality. His research has resulted in over 30 peer-reviewed publications, along with many more whitepaper and blog articles.
Aaron Anderson is the medical segment leader at Stratasys, a global leader in additive manufacturing.
